Sagentia Ventilator: Search for International Partners

Sagentia is seeking to identify partners in countries around the world to manufacture and distribute our product in their local markets. If you believe that your organisation has the capacity to help, please scroll down to fill in the form.

About Sagentia Ventilator

Overview                                                                                                                                                                                                                                                                                                                               

The Sagentia ventilator has been designed in accordance with the UK Government’s Rapidly manufactured Ventilator System (RMVS) programme launched in response to the Covid-19 pandemic of 2020. The device is in the process of being MHRA approved and being placed into NHS hospitals (April 2020).

Key Features

The device meets the UK Government specification for critical care ventilators as set out in March 2020 and is designed for use in an ICU for patients suffering from Acute respiratory distress syndrome (ARDS), a serious complication of Covid-19. The approach Sagentia design team took was to minimise the use of sourced components – which are in high demand – and to use parts that can be easily fabricated at a wide range of manufacturing facilities. The device is differentiated from other mainstream ventilator devices as it:

  • Is constructed from parts that can be fabricated using simple 2D techniques such as laser-cutting technology and CNC machining
  • Is designed for straightforward mechanical manual assembly
  • Has an intuitive user experience (UX) with physical manual controls as opposed to a touch screen interface
  • Is designed for low-cost construction and assembly

Sagentia Ventilator meets the clinical specification as set out by the UK government and can be found here.

Sagentia Ventilator references

  • The UK Government announced Sagentia’s participation in the RMVS programme and its intention to purchase ventilators from Sagentia on 31st March 2020. Full details can be found here
  • Sagentia’s parent company, Science Group plc, announced it participation in the RMVS scheme on 31st March. Details can be found here.

The Sagentia Ventilator progress was widely covered in the British and International media in March and April 2020.

Read more about Sagentia here.

Contact us

Complete our contact form to find out more.